Edition:
United States

Analyst Research

Report Title Price
Provider : GlobalData
$300.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Charles River Laboratories International Inc reaffirms FY 2014 revenue guidance; raises FY 2014 EPS guidance


Wednesday, 6 Aug 2014 04:40pm EDT 

Charles River Laboratories International Inc:Expects FY 2014 net sales growth of 9.0 - 11.0 pct.Expects FY 2014 GAAP EPS of $2.60 - $2.70 (prior $2.64 - $2.74).Expects FY 2014 Non-GAAP EPS of $3.25 - $3.35 (prior $3.15 - $3.25).FY 2014 revenue of $1.28 billion and EPS of $3.21 - Thomson Reuters I/B/E/S.